T. C. M. Morris

Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres

P Windrum, T. C. M. Morris, Mary Drake et al. · Bone Marrow Transplantation · 2005 · 210 citations

Medicine, Hematology, Cell Therapy +7

Comparative Selectivity and Specificity of the Proteasome Inhibitors BzLLLCOCHO, PS-341, and MG-132

Lisa Crawford, Brian Walker, Huib Ovaa et al. · Cancer Research · 2006 · 155 citations

Life Sciences, Molecular Biology, Pharmacology +13

High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial

Gordon Cook, Cathy Williams, Julia Brown et al. · The Lancet Oncology · 2014 · 151 citations · Full text

Medicine, Oncology, Cell Therapy +16

The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial

Gordon Cook, A. John Ashcroft, David A. Cairns et al. · The Lancet Haematology · 2016 · 149 citations

Medicine, Hematology, Oncology +14

Changes in Natural Killer Cells, the CD57CD8 Subset, and Related Cytokines in Healthy Aging

Susan McNerlan, Irene Maeve Rea, H. Denis Alexander et al. · Journal of Clinical Immunology · 1998 · 78 citations

Life Sciences, Cell Biology, Immunology +17